Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZCQ parasitological clearance and pharmacokinetics study in asymptomatic pregnant women with Plasmodium falciparum parasitemia
2014-004906-14Phase 3
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azithromycin and chloroquine in Falciparum malaria (PF), sponsored by Pfizer. Primary endpoint: Percentage of subjects with parasitological response at Day 28.
02
Drugs
azithromycinchloroquine
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on 2014-004906-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004906-14.